Yingying Qian

1.2k citations
43 papers · 904 indexed · h-index 19
Topics
Cancer-related molecular mechanisms research (6 papers)Metastasis and carcinoma case studies (5 papers)Inflammatory Biomarkers in Disease Prognosis (5 papers)
Partner nations
ChinaNorwayHong Kong

In The Last Decade

Yingying Qian

42 papers receiving 892 citations

Peers

Yingying Qian
Comparison fields: 5 of 90
  • Molecular Biology 479
  • Cancer Research 319
  • Oncology 207
  • Pulmonary and Respiratory Medicine 162
  • Surgery 95
Replace Xiaokun Ma with:
Xiaokun Ma China
Hongyan Sun China
Rafia S. Al‐Lamki United Kingdom
Eun-Jin Yeo United States
Xiaoqing Jia China
Xinrui Tian China
Jian Bai China
Lushun Yuan China
Shuqiu Chen China
Yingying Qian relative to Xiaokun Ma China Xiaokun Ma's profile →
Citations per field
00.5×1.5×
Xiaokun Ma · 1×
Citations per year

Countries citing papers authored by Yingying Qian

Since Specialization
Citations

This map shows the geographic impact of Yingying Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingying Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingying Qian more than expected).

Fields of papers citing papers by Yingying Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingying Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingying Qian. The network helps show where Yingying Qian may publish in the future.

Co-authorship network of co-authors of Yingying Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Yingying Qian. A scholar is included among the top collaborators of Yingying Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingying Qian. Yingying Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 4
4 59
5 33
6 6
7 29
8
Morpho-physiological responses of an aluminum-stressed rice variety 'Liangyoupei 9'.
3
9 21
10 18
11 19
12 19
13 47
14 16
15 19
16 7
17 50
18 1
19 13
20 35

About Yingying Qian

Yingying Qian is a scholar working on Nephrology, Cancer Research and Oncology, having authored 43 papers that have together received 904 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Metastasis and carcinoma case studies (5 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). The work is most often cited by research in Cancer Research (319 citations), Nephrology (86 citations) and Oncology (207 citations). Yingying Qian has collaborated with scholars based in China, Norway and Hong Kong. Frequent co-authors include Surong Fang, Hai Zhong, Yiqian Liu, Wei Gu, Yongqian Shu, Yucheng Yan, Xiaofeng Chen, Renhua Lu, Dong Pei and Fang Zhu. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Nature Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026